BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19449150)

  • 1. Genetic and clinical profile of Indian patients of idiopathic restrictive cardiomyopathy with and without hypertrophy.
    Rai TS; Ahmad S; Ahluwalia TS; Ahuja M; Bahl A; Saikia UN; Singh B; Talwar KK; Khullar M
    Mol Cell Biochem; 2009 Nov; 331(1-2):187-92. PubMed ID: 19449150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic disparity and identification of two TNNI3 gene mutations, one novel and one arising de novo, in South African patients with restrictive cardiomyopathy and focal ventricular hypertrophy.
    Mouton JM; Pellizzon AS; Goosen A; Kinnear CJ; Herbst PG; Brink PA; Moolman-Smook JC
    Cardiovasc J Afr; 2015; 26(2):63-9. PubMed ID: 25940119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
    Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
    J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.
    Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ
    J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of Arginine to Glutamine substitution at 98, 141 and 162 positions in Troponin I (TNNI3) associated with hypertrophic cardiomyopathy among Indians.
    Rani DS; Nallari P; Priyamvada S; Narasimhan C; Singh L; Thangaraj K
    BMC Med Genet; 2012 Aug; 13():69. PubMed ID: 22876777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype phenotype correlations of cardiac beta-myosin heavy chain mutations in Indian patients with hypertrophic and dilated cardiomyopathy.
    Rai TS; Ahmad S; Bahl A; Ahuja M; Ahluwalia TS; Singh B; Talwar KK; Khullar M
    Mol Cell Biochem; 2009 Jan; 321(1-2):189-96. PubMed ID: 18953637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Restrictive Cardiomyopathy: Causes and Consequences-An Integrative Approach.
    Cimiotti D; Budde H; Hassoun R; Jaquet K
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33429969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy.
    Mogensen J; Murphy RT; Kubo T; Bahl A; Moon JC; Klausen IC; Elliott PM; McKenna WJ
    J Am Coll Cardiol; 2004 Dec; 44(12):2315-25. PubMed ID: 15607392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incident Atrial Fibrillation Is Associated With MYH7 Sarcomeric Gene Variation in Hypertrophic Cardiomyopathy.
    Lee SP; Ashley EA; Homburger J; Caleshu C; Green EM; Jacoby D; Colan SD; Arteaga-Fernández E; Day SM; Girolami F; Olivotto I; Michels M; Ho CY; Perez MV;
    Circ Heart Fail; 2018 Sep; 11(9):e005191. PubMed ID: 30354366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinico-pathological evaluation of restrictive cardiomyopathy (endomyocardial fibrosis and idiopathic restrictive cardiomyopathy) in India.
    Seth S; Thatai D; Sharma S; Chopra P; Talwar KK
    Eur J Heart Fail; 2004 Oct; 6(6):723-9. PubMed ID: 15542407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations.
    Mogensen J; Kubo T; Duque M; Uribe W; Shaw A; Murphy R; Gimeno JR; Elliott P; McKenna WJ
    J Clin Invest; 2003 Jan; 111(2):209-16. PubMed ID: 12531876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of mutations in symptomatic patients with hypertrophic cardiomyopathy in Taiwan.
    Chiou KR; Chu CT; Charng MJ
    J Cardiol; 2015 Mar; 65(3):250-6. PubMed ID: 25086479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of R403WMYH7 and R92WTNNT2 HCM families: mutations determine left ventricular dimensions but not wall thickness during disease progression.
    Revera M; Van der Merwe L; Heradien M; Goosen A; Corfield VA; Brink PA; Moolman-Smook JC
    Cardiovasc J Afr; 2007; 18(3):146-53. PubMed ID: 17612745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sudden cardiac death in hypertrophic cardiomyopathy. Variability in phenotypic expression of beta-myosin heavy chain mutations.
    Marian AJ; Mares A; Kelly DP; Yu QT; Abchee AB; Hill R; Roberts R
    Eur Heart J; 1995 Mar; 16(3):368-76. PubMed ID: 7789380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy.
    Núñez L; Gimeno-Blanes JR; Rodríguez-García MI; Monserrat L; Zorio E; Coats C; McGregor CG; Hernandez del Rincón JP; Castro-Beiras A; Hermida-Prieto M
    Circ J; 2013; 77(9):2358-65. PubMed ID: 23782526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of Hypertrophic Cardiomyopathy Related Gene Mutations and Clinical Manifestations in Vietnamese Patients With Hypertrophic Cardiomyopathy.
    Tran Vu MT; Nguyen TV; Huynh NV; Nguyen Thai HT; Pham Nguyen V; Ho Huynh TD
    Circ J; 2019 Aug; 83(9):1908-1916. PubMed ID: 31308319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy.
    Erdmann J; Daehmlow S; Wischke S; Senyuva M; Werner U; Raible J; Tanis N; Dyachenko S; Hummel M; Hetzer R; Regitz-Zagrosek V
    Clin Genet; 2003 Oct; 64(4):339-49. PubMed ID: 12974739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations.
    Maron BJ; Niimura H; Casey SA; Soper MK; Wright GB; Seidman JG; Seidman CE
    J Am Coll Cardiol; 2001 Aug; 38(2):315-21. PubMed ID: 11499718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
    Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
    Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYBPH acts as modifier of cardiac hypertrophy in hypertrophic cardiomyopathy (HCM) patients.
    Mouton JM; van der Merwe L; Goosen A; Revera M; Brink PA; Moolman-Smook JC; Kinnear C
    Hum Genet; 2016 May; 135(5):477-483. PubMed ID: 26969327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.